Acro-Trestolone (Ment) at a Glance
Acro-Trestolone, commonly known as MENT (7α-methyl-19-nortestosterone), is a potent synthetic anabolic-androgenic steroid derived from nandrolone with enhanced bioactivity characteristics. This 50mg/ml injectable formulation from Beligas Pharma represents a research-grade compound for investigating advanced steroid receptor mechanisms and tissue-selective androgen activity. At Stroid UK Shop, our laboratory-verified Acro-Trestolone enables researchers to examine one of the most potent androgens developed for preclinical studies. The methylation at the 7α position significantly increases binding affinity to androgen receptors while conferring resistance to 5α-reductase metabolism, making it an invaluable tool for receptor selectivity research.
Laboratory Applications
Research applications for Acro-Trestolone centre on its unique pharmacological profile as both an androgen and progestogen receptor agonist. Studies investigate its tissue-selective effects on muscle protein synthesis, bone mineralisation pathways, and hypothalamic-pituitary-gonadal axis modulation. The compound’s resistance to aromatisation while maintaining potent androgenic activity makes it particularly valuable for examining direct androgen receptor-mediated pathways without confounding estrogenic effects. Researchers studying steroid injection mechanisms utilise MENT to investigate dose-response relationships in androgen-sensitive tissues. Additionally, its progestational activity provides insights into multi-receptor steroid interactions. Comparative studies with SARM compounds examine tissue selectivity differences, while metabolic investigations explore its effects on nitrogen retention and protein turnover. Some research protocols combine analysis with peptide research chemicals to examine synergistic receptor pathways in cellular models.
Research Specifications
| Concentration | 50mg/ml |
|---|---|
| Volume | 10ml vial |
| CAS Number | 3764-87-2 |
| Molecular Formula | C₁₉H₂₈O₂ |
| Molecular Weight | 288.42 g/mol |
| Purity | ≥98% (HPLC verified) |
| Storage | Room temperature, protect from light |
| Stability | 36 months when stored properly |
Research Compliance
This Acro-Trestolone formulation is manufactured by Beligas Pharma exclusively for in-vitro laboratory research and analytical testing purposes. The compound is not intended for human consumption, clinical application, or any form of in-vivo administration. Researchers must ensure compliance with local regulations governing controlled research substances and maintain appropriate laboratory safety protocols. All studies should be conducted within approved research facilities with proper ventilation and safety equipment. This product is restricted to qualified research institutions and licensed investigators studying steroid biochemistry, receptor pharmacology, or related analytical chemistry applications.
